Use of cell free DNA in breast oncology

Jenna Canzoniero, Ben Ho Park

Research output: Contribution to journalArticle

Abstract

Cell free DNA (cfDNA) are short fragments of nucleic acids present in circulation outside of cells. In patients with cancer, some portion of cfDNA is derived from tumor cells, termed circulating tumor DNA (ctDNA), and contains the same mutations and genetic changes as the cancer. The development of new, more effective methods to detect these changes has led to increased interest in developing ctDNA as a biomarker for cancer. Here we will review current literature on the use of ctDNA, with an emphasis on breast cancer, for cancer detection, prognosis, monitoring response to therapy, and tracking the rise of new mutant subclones.

Original languageEnglish (US)
Pages (from-to)266-274
Number of pages9
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1865
Issue number2
DOIs
Publication statusPublished - Apr 1 2016

    Fingerprint

Keywords

  • Breast cancer
  • Cell free DNA
  • Circulating tumor DNA
  • Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Genetics

Cite this